InnoTherapy Inc - ESG Rating & Company Profile powered by AI
Other companies in the scoring peer group for InnoTherapy Inc are displayed. Browse to the bottom of this page for potential risks for InnoTherapy Inc based on sector, location and marketcap. This Sustainability score for InnoTherapy Inc indicates its transparency towards the UN Sustainable Development Goals.
InnoTherapy Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | InnoTherapy Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does InnoTherapy Inc have an accelerator or VC vehicle to help deliver innovation?
Does InnoTherapy Inc disclose current and historical energy intensity?
Does InnoTherapy Inc report the average age of the workforce?
Does InnoTherapy Inc reference operational or capital allocation in relation to climate change?
Does InnoTherapy Inc disclose its ethnicity pay gap?
Does InnoTherapy Inc disclose cybersecurity risks?
Does InnoTherapy Inc offer flexible work?
Does InnoTherapy Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does InnoTherapy Inc disclose the number of employees in R&D functions?
Does InnoTherapy Inc conduct supply chain audits?
Does InnoTherapy Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does InnoTherapy Inc conduct 360 degree staff reviews?
Does InnoTherapy Inc disclose the individual responsible for D&I?
Does InnoTherapy Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does InnoTherapy Inc disclose current and / or historical scope 2 emissions?
Does InnoTherapy Inc disclose water use targets?
Does InnoTherapy Inc have careers partnerships with academic institutions?
Did InnoTherapy Inc have a product recall in the last two years?
Does InnoTherapy Inc disclose incidents of discrimination?
Does InnoTherapy Inc allow for Work Councils/Collective Agreements to be formed?
Has InnoTherapy Inc issued a profit warning in the past 24 months?
Does InnoTherapy Inc disclose parental leave metrics?
Does InnoTherapy Inc disclose climate scenario or pathway analysis?
Does InnoTherapy Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does InnoTherapy Inc disclose the pay ratio of women to men?
Does InnoTherapy Inc support suppliers with sustainability related research and development?
Does InnoTherapy Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does InnoTherapy Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is InnoTherapy Inc involved in embryonic stem cell research?
Does InnoTherapy Inc disclose GHG and Air Emissions intensity?
Does InnoTherapy Inc disclose its waste policy?
Does InnoTherapy Inc report according to TCFD requirements?
Does InnoTherapy Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does InnoTherapy Inc disclose energy use targets?
Does InnoTherapy Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does InnoTherapy Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for InnoTherapy Inc
These potential risks are based on the size, segment and geographies of the company.
InnoTherapy, Inc., engages in the development and sale of medical sealant products in South Korea. The company's products include InnoSEAL, an externally applied hemostatic agent; InnoSEAL Plus, an absorbable hemostatic pad; EndoSil, an absorbable hemostatic agent used for the gastrointestinal oozing bleeding; GellySil, a biomaterial and the proprietary material product. It also provides Film-type surgical sealant to complete sealing of anastomosis site; STOP needle, a self-sealing needle for general and ophthalmic use; wound dressing used for chronic wounds, burns, etc.; and Gene therapy, a bio-therapeutics delivery system. The company was founded in 2010 and is headquartered in Seoul, South Korea.